Sector consensus Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 217.74 USD | +0.62% |
|
+0.00% | +8.04% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | $205 | -5.26% | 14 | ||||||
| CHF 678.09 | +21.52% | 22 | ||||||
| $259.15 | +7.38% | 20 | ||||||
| $404.82 | +16.75% | 25 | ||||||
| ₩235,751.77 | +11.47% | 22 | ||||||
| $91.89 | -24.2% | 18 | ||||||
| $542.33 | -12.02% | 12 | ||||||
| €67.85 | -5.76% | 15 | ||||||
| $205.69 | +11.32% | 16 | ||||||
| $226.49 | +21.71% | 15 | ||||||
| $90.49 | +14.73% | 22 | ||||||
| $87.92 | +26.9% | 12 | ||||||
| $70 | +2.34% | 12 | ||||||
| $52.82 | +11.34% | 14 | ||||||
| €109.03 | +0.96% | 5 | ||||||
| CN¥36.65 | +11.36% | 11 | ||||||
| $462.53 | +54.97% | 15 | ||||||
| CN¥65.86 | +4.55% | 13 | ||||||
| Average | 13,300.47 | +9.45% | 16 | ||||||
| Weighted average by Cap. | 22,654.83 | +9.42% | 18 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition